Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Accounts Payables (2020 - 2025)

Agilon Health's Accounts Payables history spans 6 years, with the latest figure at $127.5 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 42.15% year-over-year to $127.5 million; the TTM value through Dec 2025 reached $127.5 million, down 42.15%, while the annual FY2025 figure was $127.5 million, 42.15% down from the prior year.
  • Accounts Payables reached $127.5 million in Q4 2025 per AGL's latest filing, down from $145.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $290.6 million in Q3 2023 to a low of $95.1 million in Q1 2021.
  • Average Accounts Payables over 5 years is $185.7 million, with a median of $174.7 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: surged 81.5% in 2023, then crashed 42.15% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $112.9 million in 2021, then surged by 57.09% to $177.4 million in 2022, then soared by 34.95% to $239.4 million in 2023, then decreased by 7.97% to $220.3 million in 2024, then plummeted by 42.15% to $127.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Accounts Payables are $127.5 million (Q4 2025), $145.5 million (Q3 2025), and $171.9 million (Q2 2025).